18th May 2016 07:01
LONDON (Alliance News) - Animal genetics company Genus PLC on Wednesday said it has signed a multi-year collaboration with Caribou Biosciences Inc which will give Genus a worldwide, exclusive licence to Caribou's CRISPR-Cas9 gene editing technology platform.
CRISPR-Cas9 targets and cuts DNA to produce precise and controllable changes to the genome for certain livestock species, Genus said.
Genus will get access to the platform for the development of new genetic traits in pigs, cattle and potentially other livestock species. No financial details on the agreement were disclosed, but Genus will pay Caribou an upfront fee along with commercial milestone payments and royalties on licensed product sales.
The pair will also work on a four-year research project, funded by Genus, which will initially focus on developing and optimising Genus's Porcine Reproductive & Respiratory Syndrome Virus-resistant pigs.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Genus